Immutep Limited PBMD
No live quote for PBMD yet.
Analyst view
Consensus: buy
Buy
Price target (mean) 6.99
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
- 2 months ago 1
- 3 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 11.64M | +265.1% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 11.64M | +265.1% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 11.64M | +265.1% | 0 |
| Next year | -0.27 | -0.70 – -0.02 | 0.00 | 0.0% | 1.53M | -86.8% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 17, 2016 | Maxim Group | Initiated | — | Buy |
| Dec 29, 2015 | Roth Capital | Initiated | — | Buy |
| Dec 2, 2015 | FBR Capital | Initiated | — | Outperform |
| Oct 13, 2015 | H.C. Wainwright | Initiated | — | Buy |